Results 11 to 20 of about 4,708,479 (153)

A Bayesian framework for virtual comparative trials and bioequivalence assessments [PDF]

open access: yesFrontiers in Pharmacology
IntroductionIn virtual bioequivalence (VBE) assessments, pharmacokinetic models informed with in vitro data and verified with small clinical trials’ data are used to simulate otherwise unfeasibly large trials.
Frederic Y. Bois, Céline Brochot
doaj   +6 more sources

Virtual population pharmacokinetic using physiologically based pharmacokinetic model for evaluating bioequivalence of oral lacidipine formulations in dogs

open access: yesAsian Journal of Pharmaceutical Sciences, 2017
The aim of the present study was to investigate virtual population pharmacokinetic using physiologically based pharmacokinetic (PBPK) model for evaluating bioequivalence of oral lacidipine formulations in dogs.
Bin Yang   +6 more
doaj   +6 more sources

An Open‐Source Framework for Virtual Bioequivalence Modeling and Clinical Trial Design [PDF]

open access: yesCPT: Pharmacometrics & Systems Pharmacology
To establish bioequivalence (BE) of a generic test formulation with respect to a reference listed drug, it is necessary to demonstrate a comparable rate and extent to which active ingredients reach the site of action.
Abdullah Hamadeh   +13 more
doaj   +4 more sources

Proof of Concept in Assignment of Within-Subject Variability During Virtual Bioequivalence Studies: Propagation of Intra-Subject Variation in Gastrointestinal Physiology Using Physiologically Based Pharmacokinetic Modeling [PDF]

open access: yesAAPS Journal, 2022
AbstractWhile the concept of ‘Virtual Bioequivalence’ (VBE) using a combination of modelling, in vitro tests and integration of pre-existing data on systems and drugs is growing from its infancy, building confidence on VBE outcomes requires demonstration of its ability not only in predicting formulation-dependent systemic exposure but also the expected
Rodrigo Cristofoletti   +2 more
exaly   +5 more sources

Virtual Trial Comparisons and Bioequivalence Assessment: From Data-Based to Probabilistic Assessment [PDF]

open access: yes, 2023
The recent emergence of virtual trial comparisons, in particular for virtual bioequivalence (VBE) assessment, begs for sound statistical analyses of their results. In recent VBE assessments, pharmacokinetic models informed with in vitro data and verified
Bois, Frederic Yves, Brochot, Céline
core   +5 more sources

Narrow Therapeutic Index Drugs: Regulatory Frameworks, Bioequivalence, and Model-Informed Precision Dosing [PDF]

open access: yesPharmaceutics
Background/Objectives: Narrow therapeutic index (NTI) drugs are characterized by a small margin between effective and toxic exposure. This review aimed to summarize international definitions and regulatory frameworks for NTI drugs, compare bioequivalence
Mengmeng Liu   +7 more
doaj   +2 more sources

DoE- and PBBM-Driven Formulation Development of an Extended-Release Donepezil Tablet [PDF]

open access: yesPharmaceuticals
Background/Objectives: This study explores the integration of Design of Experiments (DoE) with Physiologically Based Biopharmaceutics Modeling (PBBM) to streamline the development of extended-release (XR) formulations.
Frederico Severino Martins   +4 more
doaj   +2 more sources

Introducing an Artificial Neural Network for Virtually Increasing the Sample Size of Bioequivalence Studies

open access: yesApplied Sciences
Sample size is a key factor in bioequivalence and clinical trials. An appropriately large sample is necessary to gain valuable insights into a designated population.
Dimitris Papadopoulos   +1 more
doaj   +2 more sources

Numerical Verification of Tucuxi, a Promising Bayesian Adaptation Tool for Model‐Informed Precision Dosing [PDF]

open access: yesCPT: Pharmacometrics & Systems Pharmacology
Tucuxi, a Swiss‐developed Model‐Informed Precision Dosing (MIPD) software, aims to support clinical dosage decision‐making to achieve therapeutic concentration targets.
Anne Ravix   +5 more
doaj   +2 more sources

Virtual Bioequivalence Assessment of Long-acting Injectable Suspensions Using PBPK Modeling: Part 1. Impact of particle Size on Formulation Variability. [PDF]

open access: yesAAPS J
This study presents a workflow for virtual bioequivalence (VBE) assessment of 3-month paliperidone palmitate (PP) long-acting injectable (LAI) suspensions using a novel physiologically based pharmacokinetic (PBPK) model. The mechanistic absorption and PBPK model was implemented in the Simcyp® Simulator and calibrated against individual concentration ...
Morris NM   +12 more
europepmc   +8 more sources

Home - About - Disclaimer - Privacy